Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

I would have sworn that at one point they were calling K a 1b/2a. Maybe not.

Look...if a mid stage trial is anything beyond a phase 1, then I'll concede the point. But I'm sure you won't try to persuade me that the P 2b and the UP PoC or K 2a are of equal impact or significance.

According to -- https://www.fda.gov/forpatients/approvals/drugs/ucm405622.htm -- phase 2s are up to several hundred people. Not all phase 2 trials are created equally.

Don't interpret what I'm saying to mean that the K 2a and UP PoC aren't important.